Translational research and innovative therapies have opened new frontiers in understanding atopic dermatitis (AD), focusing on key areas such as abnormal immune responses, pruritus, microbial ...
In allergen-driven models of atopic dermatitis, subcutaneous (SQ) administration of ‘1104 demonstrated comparable performance to intravenous administration (IV) In multiple preclinical models ...